ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,539Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 1454

$1.57M Total Retail Price of All Prescriptions

Rank: 20 out of 1454

874 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 874 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 874 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

4% of this provider’s 26,043 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
SIMVASTATIN 1,450 1,263 1 1
AMLODIPINE BESYLATE 1,421 1,192 2 2
POTASSIUM CHLORIDE 1,200 975 3 15
FUROSEMIDE 913 786 4 6
LEVOTHYROXINE SODIUM 897 759 5 5
OMEPRAZOLE 715 602 6 3
TRIAMTERENE-HCTZ 713 591 10 7 44
METOPROLOL TARTRATE 660 588 8 10
BENAZEPRIL HCL 656 553 9 57
HYDROCHLOROTHIAZIDE 591 495 10 9
WARFARIN SODIUM 575 504 11 17
LISINOPRIL 543 496 12 4
ATENOLOL 534 446 13 18
METOPROLOL SUCCINATE 518 486 14 13
NEXIUM 516 415 15 23
GLYBURIDE 487 443 R 16 98
SERTRALINE HCL 454 396 17 26
METFORMIN HCL 445 354 18 8
HYDROCODONE-ACETAMINOPHEN 388 336 S3 19 7
ATORVASTATIN CALCIUM 335 293 20 11
PRAVASTATIN SODIUM 333 274 21 12
LOSARTAN POTASSIUM 330 278 22 14
DIOVAN 308 283 23 40
ZOLPIDEM TARTRATE 274 242 24 19
SYNTHROID 255 222 25 25
ALLOPURINOL 246 242 26 28
GLIMEPIRIDE 243 208 27 33
ALENDRONATE SODIUM 242 219 28 35
CLONIDINE HCL 241 150 29 49
CRESTOR 231 190 30 22
DIGOXIN 228 202 31 70
AMLODIPINE BESYLATE-BENAZEPRIL 222 200 32 65
LOSARTAN-HYDROCHLOROTHIAZIDE 215 205 33 38
CITALOPRAM HBR 213 195 34 21
KLOR-CON M20 200 166 35 54
CLOPIDOGREL 190 169 36 32
LANSOPRAZOLE 178 169 37 140
SPIRONOLACTONE 176 123 38 63
DILTIAZEM 24HR CD 174 152 39 76
INDAPAMIDE 174 157 39 184
LANTUS 165 121 41 51
MELOXICAM 163 145 42 37
LOVASTATIN 160 160 43 39
PROAIR HFA 159 130 44 56
TRIAMTERENE-HYDROCHLOROTHIAZID 157 131 45 168
GABAPENTIN 151 109 46 16
ACTOS 148 107 47 90
PREDNISONE 142 131 48 36
LIPITOR 141 124 49 74
CARVEDILOL 141 111 49 24
DOXAZOSIN MESYLATE 141 104 49 87
PLAVIX 138 128 52 45
AMITRIPTYLINE HCL 137 105 R 53 71
GLYBURIDE-METFORMIN HCL 134 103 R 54 139
ADVAIR DISKUS 134 108 54 47
TRAMADOL HCL 133 120 56 20
VERAPAMIL ER 128 105 57 89
EVISTA 127 127 58 136
DONEPEZIL HCL 126 126 59 29
COMBIVENT 125 97 60 115
DIOVAN HCT 123 87 61 75
CEFUROXIME 122 112 62 150
GEMFIBROZIL 120 101 63 128
ISOSORBIDE MONONITRATE ER 116 110 64 46
NOVOLIN 70-30 116 80 64 237
CYCLOBENZAPRINE HCL 115 107 R 66 59
ONGLYZA 113 103 67 197
FLUOXETINE HCL 113 110 67 72
PAROXETINE HCL 111 105 69 73
VYTORIN 111 62 69 170
INSULIN SYRINGE 105 61 71 97
NIFEDIPINE ER 105 90 71 102
NAMENDA 100 100 73 48
PANTOPRAZOLE SODIUM 98 83 74 31
POLYETHYLENE GLYCOL 3350 97 91 75 61
HYDRALAZINE HCL 97 72 75 67
ESCITALOPRAM OXALATE 96 87 77 78
PREMARIN 96 83 R 77 131
OXYCODONE-ACETAMINOPHEN 93 80 S2 79 60
METOCLOPRAMIDE HCL 93 61 79 121
CIPROFLOXACIN HCL 90 84 81 64
FINASTERIDE 88 88 82 94
CLOTRIMAZOLE-BETAMETHASONE 87 69 83 166
LISINOPRIL-HYDROCHLOROTHIAZIDE 87 83 83 27
METFORMIN HCL ER 86 86 85 41
LEVOXYL 85 73 86 84
GLIPIZIDE 84 63 87 62
PEN NEEDLE 83 54 88 113
RAMIPRIL 81 69 89 66
TAMSULOSIN HCL 79 61 90 34
HUMULIN 70-30 79 42 90 241
NIFEDIAC CC 78 61 92 246
GLIPIZIDE XL 75 75 93 85
ENALAPRIL MALEATE 75 53 93 58
COLCRYS 75 71 93 116
BENAZEPRIL-HYDROCHLOROTHIAZIDE 73 73 96 167
PIOGLITAZONE HCL 73 54 R 96 235
LYRICA 71 56 98 103
CLONIDINE 70 52 99 252
RANITIDINE HCL 68 55 100 43
RISPERIDONE 68 62 100 86
ESTRADIOL 67 50 R 102 164
EXELON 67 67 102 135
NITROGLYCERIN PATCH 66 66 104 190
TRAZODONE HCL 65 48 105 50
PROPRANOLOL HCL 64 54 106 129
LANTUS SOLOSTAR 64 51 106 79
CARBAMAZEPINE 61 49 108 230
NOVOLIN R 61 52 108 180
MECLIZINE HCL 60 58 110 132
SPIRIVA 59 59 111 52
AVELOX 58 50 112 298
PROVENTIL HFA 57 48 113 395
VENLAFAXINE HCL ER 57 29 113 105
COUMADIN 56 56 115 119
DILTIAZEM ER 56 56 115 126
BENICAR 55 55 117 189
ENABLEX 55 53 117 313
BYSTOLIC 54 54 119 110
GLIPIZIDE ER 54 54 119 92
KLOR-CON 10 53 53 121 141
DETROL LA 51 49 122 225
TOPROL XL 51 47 122 231
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 16, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.